Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/9d/8f/67/9d8f676a-85ad-dba5-84f4-c4ba2684d129/mza_705242844563708402.jpg/600x600bb.jpg
ERS Publications Podcasts
ERS Publications Podcasts
75 episodes
2 weeks ago
As part of the October issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Section Editor Isabella Annesi-Maesano about natural disasters and respiratory health, as discussed in his review article in this issue of the ERJ: https://doi.org/10.1183/13993003.02563-2024 Cite this podcast as: ERJ Podcast October 2025: Natural disasters and respiratory health. Eur Respir J 2025; 66: 25E6604 [https://doi.org/10.1183/13993003.E6604-2025]
Show more...
Science
RSS
All content for ERS Publications Podcasts is the property of ERS Publications Podcasts and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
As part of the October issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Section Editor Isabella Annesi-Maesano about natural disasters and respiratory health, as discussed in his review article in this issue of the ERJ: https://doi.org/10.1183/13993003.02563-2024 Cite this podcast as: ERJ Podcast October 2025: Natural disasters and respiratory health. Eur Respir J 2025; 66: 25E6604 [https://doi.org/10.1183/13993003.E6604-2025]
Show more...
Science
https://i1.sndcdn.com/avatars-L1X78frvBQfa8XCu-2TqonA-original.jpg
ERJ Podcast May 2025: Efficacy and safety of the activin signalling inhibitor sotatercept
ERS Publications Podcasts
15 minutes 24 seconds
5 months ago
ERJ Podcast May 2025: Efficacy and safety of the activin signalling inhibitor sotatercept
As part of the May issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Marius Hoeper about the efficacy and safety of the activin signalling inhibitor sotatercept in a pooled analysis of PULSAR and STELLAR studies.
ERS Publications Podcasts
As part of the October issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy Chief Editor Don Sin interviews Section Editor Isabella Annesi-Maesano about natural disasters and respiratory health, as discussed in his review article in this issue of the ERJ: https://doi.org/10.1183/13993003.02563-2024 Cite this podcast as: ERJ Podcast October 2025: Natural disasters and respiratory health. Eur Respir J 2025; 66: 25E6604 [https://doi.org/10.1183/13993003.E6604-2025]